[Mauvais contrôle des facteurs de risque cardiovasculaire modifiables chez les patients congolais en phase aiguë et séquellaire d'un accident vasculaire cérébral : Une étude transversale].
Poor control of modifiable cardiovascular risk factors among Congolese patients in the acute and sequelae phase of stroke : A cross-sectional study.
Cardiovascular
Congolese
Control
Contrôle
Risk
Stroke
accident vasculaire cérébral
cardiovasculaire
congolais
facteurs
factors
risque
Journal
Annales de cardiologie et d'angeiologie
ISSN: 1768-3181
Titre abrégé: Ann Cardiol Angeiol (Paris)
Pays: France
ID NLM: 0142167
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
01
06
2023
revised:
04
07
2023
accepted:
19
07
2023
pubmed:
28
8
2023
medline:
28
8
2023
entrez:
28
8
2023
Statut:
ppublish
Résumé
To assess the level of the control of the cardiovascular risk factors in patients with a history of stroke in the Democratic Republic of the Congo. The level of the control of arterial hypertension, diabetes mellitus, and dyslipidemias was analyzed in two hundred and seventy-four (274) patients followed for stroke. Among 188 patients with a prior diagnosis of arterial hypertension, only 100 (53.2%) were treated, 27 (27.0%) had their blood pressure well controlled [12.3% in acute stroke vs. 46.5% in sequelae phase; p = 0.0002]. Among 42 (71.2%) diabetics treated, 23 (63.9%) had glycaemia levels > 200 mg/dl, 60.0% in acute phase and 83.3% in sequelae phase (p = 0.28). Finally, 87.0% of the patients had a non-HDL-C > 85 mg/dl. This study shows a poor control of modifiable cardiovascular risk factors in patients with very high cardiovascular risk due to stroke. There is a need for an effective program to combat non-communicable diseases in our environment.
Identifiants
pubmed: 37639739
pii: S0003-3928(23)00069-0
doi: 10.1016/j.ancard.2023.101634
pii:
doi:
Types de publication
English Abstract
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
101634Informations de copyright
Copyright © 2023 Elsevier Masson SAS. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no competing interests.